Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan E Bates

Showing results (81-90 of 293) with videos related to

Pageof 30
Sort By:
Journal of the National Cancer Institute|November 3, 2011
Potential pitfalls of crossover and thoughts on iniparib in triple-negative breast cancerTito Fojo, Laleh Amiri-Kordestani, Susan E Bates
Seminars in Oncology|January 3, 2024
Beyond BRCA: Diagnosis and management of homologous recombination repair deficient pancreatic cancerMeredith LaRose, Gulam A Manji, Susan E Bates
The Oncologist|February 12, 2020
Prevention of Venous Thromboembolism in Pancreatic Cancer: Breaking Down a Complex Clinical DilemmaMatthew C Dallos, Andrew B Eisenberger, Susan E Bates
The Oncologist|May 13, 2020
Emerging Therapeutic Implications of STK11 Mutation: Case SeriesBahar Laderian, Prabhjot Mundi, Tito Fojo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2015
CCR 20th Anniversary Commentary: Expanding the Epigenetic Therapeutic PortfolioSusan E Bates, Robert W Robey, Richard L Piekarz
The Oncologist|July 25, 2013
Clinical trial results: Sharing results, speeding discoveriesAntonio Tito Fojo, Susan E Bates, Bruce A Chabner
Molecular and Cellular Biology|September 7, 2006
Aberrant promoter methylation of the ABCG2 gene in renal carcinomaKenneth K W To, Z Zhan, Susan E Bates
Cancer Journal (Sudbury, Mass.)|April 28, 2007
Histone deacetylase inhibitors and demethylating agents: clinical development of histone deacetylase inhibitors for cancer therapyRichard L Piekarz, Dan L Sackett, Susan E Bates
Biochimica Et Biophysica Acta|April 3, 2007
A database study that identifies genes whose expression correlates, negatively or positively, with 5-year survival of cancer patientsWilfred D Stein, Thomas Litman, Tito Fojo, et al.
Cancer|November 24, 2021
Equipoise, drug development, and biliary cancerTristan Y Lee, Susan E Bates, Ghassan K Abou-Alfa
Pageof 30

Showing results (81-90 of 293) with videos related to

Sort By:
Pageof 30
Journal of the National Cancer Institute|November 3, 2011
Potential pitfalls of crossover and thoughts on iniparib in triple-negative breast cancerTito Fojo, Laleh Amiri-Kordestani, Susan E Bates
Seminars in Oncology|January 3, 2024
Beyond BRCA: Diagnosis and management of homologous recombination repair deficient pancreatic cancerMeredith LaRose, Gulam A Manji, Susan E Bates
The Oncologist|February 12, 2020
Prevention of Venous Thromboembolism in Pancreatic Cancer: Breaking Down a Complex Clinical DilemmaMatthew C Dallos, Andrew B Eisenberger, Susan E Bates
The Oncologist|May 13, 2020
Emerging Therapeutic Implications of STK11 Mutation: Case SeriesBahar Laderian, Prabhjot Mundi, Tito Fojo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2015
CCR 20th Anniversary Commentary: Expanding the Epigenetic Therapeutic PortfolioSusan E Bates, Robert W Robey, Richard L Piekarz
The Oncologist|July 25, 2013
Clinical trial results: Sharing results, speeding discoveriesAntonio Tito Fojo, Susan E Bates, Bruce A Chabner
Molecular and Cellular Biology|September 7, 2006
Aberrant promoter methylation of the ABCG2 gene in renal carcinomaKenneth K W To, Z Zhan, Susan E Bates
Cancer Journal (Sudbury, Mass.)|April 28, 2007
Histone deacetylase inhibitors and demethylating agents: clinical development of histone deacetylase inhibitors for cancer therapyRichard L Piekarz, Dan L Sackett, Susan E Bates
Biochimica Et Biophysica Acta|April 3, 2007
A database study that identifies genes whose expression correlates, negatively or positively, with 5-year survival of cancer patientsWilfred D Stein, Thomas Litman, Tito Fojo, et al.
Cancer|November 24, 2021
Equipoise, drug development, and biliary cancerTristan Y Lee, Susan E Bates, Ghassan K Abou-Alfa
Pageof 30